These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38551726)

  • 21. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
    Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH
    Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanism.
    Poruchynsky MS; Giannakakou P; Ward Y; Bulinski JC; Telford WG; Robey RW; Fojo T
    Biochem Pharmacol; 2001 Dec; 62(11):1469-80. PubMed ID: 11728383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel.
    Zhao W; Song Y; Xu B; Zhan Q
    Cancer Biol Ther; 2012 Feb; 13(3):156-63. PubMed ID: 22353935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-APCAs, the Novel Microtubule Targeting Agents Active Against Distinct Cancer Cell Lines.
    Boichuk S; Galembikova A; Bikinieva F; Dunaev P; Aukhadieva A; Syuzov K; Zykova S; Igidov N; Ksenofontov A; Bocharov P
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33503939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis.
    Deng S; Banerjee S; Chen H; Pochampally S; Wang Y; Yun MK; White SW; Parmar K; Meibohm B; Hartman KL; Wu Z; Miller DD; Li W
    Cancer Lett; 2023 Feb; 555():216046. PubMed ID: 36596380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer.
    Ingemarsdotter CK; Baird SK; Connell CM; Öberg D; Halldén G; McNeish IA
    Oncogene; 2010 Nov; 29(45):6051-63. PubMed ID: 20729921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
    Tripathi S; Srivastava G; Sharma A
    Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cell-based pharmacokinetics assay for evaluating tubulin-binding drugs.
    Wang Y; Liu J; Zhang J; Wang L; Chan J; Wang H; Jin Y; Yu L; Grainger DW; Ying W
    Int J Med Sci; 2014; 11(5):479-87. PubMed ID: 24688312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
    Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
    Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity.
    Du T; Lin S; Ji M; Xue N; Liu Y; Zhang Z; Zhang K; Zhang J; Zhang Y; Wang Q; Sheng L; Li Y; Lu D; Chen X; Xu H
    Cancer Lett; 2020 Dec; 495():22-32. PubMed ID: 32931884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
    Gan PP; McCarroll JA; Po'uha ST; Kamath K; Jordan MA; Kavallaris M
    Mol Cancer Ther; 2010 May; 9(5):1339-48. PubMed ID: 20442307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – a critical role of Cdk1 in mitotic entry.
    Chang WL; Yu CC; Chen CS; Guh JH
    Biochem Pharmacol; 2015 Mar; 94(1):12-21. PubMed ID: 25615907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase.
    Marcus AI; Zhou J; O'Brate A; Hamel E; Wong J; Nivens M; El-Naggar A; Yao TP; Khuri FR; Giannakakou P
    Cancer Res; 2005 May; 65(9):3883-93. PubMed ID: 15867388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytosolic Cl- Affects the Anticancer Activity of Paclitaxel in the Gastric Cancer Cell Line, MKN28 Cell.
    Tanaka S; Miyazaki H; Shiozaki A; Ichikawa D; Otsuji E; Marunaka Y
    Cell Physiol Biochem; 2017; 42(1):68-80. PubMed ID: 28554181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
    Yang H; Mao W; Rodriguez-Aguayo C; Mangala LS; Bartholomeusz G; Iles LR; Jennings NB; Ahmed AA; Sood AK; Lopez-Berestein G; Lu Z; Bast RC
    Clin Cancer Res; 2018 Oct; 24(20):5072-5084. PubMed ID: 30084832
    [No Abstract]   [Full Text] [Related]  

  • 36. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J; Sui M; Fan W
    Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
    Targa B; Klipfel L; Cantaloube I; Salameh J; Benoit B; Poüs C; Baillet A
    Cell Death Dis; 2019 Jan; 10(2):54. PubMed ID: 30670682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells.
    Lobert S; Jefferson B; Morris K
    Cytoskeleton (Hoboken); 2011 Jun; 68(6):355-62. PubMed ID: 21634028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Src family kinases and paclitaxel sensitivity.
    Le XF; Bast RC
    Cancer Biol Ther; 2011 Aug; 12(4):260-9. PubMed ID: 21646863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?
    Gielecińska A; Kciuk M; Yahya EB; Ainane T; Mujwar S; Kontek R
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189024. PubMed ID: 37980943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.